BioNet-Asia Co., Ltd.: Clinical Trials

8 trials sponsored by BioNet-Asia Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting. 2 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Active not recruiting 1, Completed 1
Phase 41Completed 1

Follow BioNet-Asia Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
Pertagen® vaccine, Adacel® vaccine - Pertussis
Phase 4CompletedMahidol University902025-05-132026-10-08
Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults
Pertussis containing vaccine - Pertussis Vaccine
Phase 3Active not recruitingBioNet-Asia Co., Ltd.23992025-02-082025-10-03
Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women
Pertussis Vaccines, Pertussis (Whooping Cough)
Active not recruitingBioNet-Asia Co., Ltd.27002024-12-122025-10-03
5-year Follow-up After a Single Dose Acellular Pertussis Vaccination
Biological/Vaccine: Pertagen (aP BioNet), Biological/Vaccine: Boostagen (TdaP BioNet), Biological/Vaccine: Adacel - Pertussis
CompletedMahidol University1592020-08-242022-01-05
Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
Combined Diphtheria-Tetanus-recombinant acellular pertussis (DTaP) vaccine, Licensed DTaP - Pertussis Whooping Cough
Phase 2 / Phase 3CompletedBioNet-Asia Co., Ltd.2902020-07-132025-10-08
Safety Monitoring of VacPertagen Vaccine in Thailand
Pertussis (Whooping Cough)
CompletedBioNet-Asia Co., Ltd.54142018-07-162026-02-10
Safety Monitoring of Boostagen® Vaccine in Thailand
Pertussis (Whooping Cough), Tetanus
CompletedBioNet-Asia Co., Ltd.107272017-06-302026-03-03
The PertADO Geneva Trial
Pertagen® aP + Td-pur®, Boostrix® dTpa - Pertussis
Phase 2CompletedSiegrist Claire-Anne602016-10-272017-05-08

Conditions studied

Whooping Cough (6)  ·  Diphtheria (1)  ·  Tetanus (1)

Interventions

Biological Products (1)  ·  Vaccines (1)

Countries

Thailand (7)  ·  Switzerland (1)

Top investigators

Claire-Anne Siegrist, MD (1)  ·  Prof. Punnee Pitisuttithum (1)  ·  Punnee Pitisuttithum (1)  ·  Punnee Pitisuttithum, MD (1)  ·  Soaud Mansouri, PhD. (1)

Results publications

PMID 30759183